ORMAT TECHNOLOGIES, INC.
Business
Ormat Technologies is a vertically integrated geothermal power company that develops, builds, owns and operates geothermal, solar PV, and recovered energy power plants globally, selling electricity under long-term PPAs. The company manufactures organic Rankine cycle power units and provides engineering, procurement and construction services. Ormat operates three business segments: Electricity, Product (equipment manufacturing and EPC services), and Energy Storage (battery storage capacity in the U.S.). The company markets solutions internationally.
Summary from 10-K filed 2026-02-26
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenues | 990 | 880 | 829 | 734 | 663 | |
| Total cost of revenues | 717 | 607 | 565 | 465 | 399 | |
| Gross profit | 273 | 273 | 264 | 269 | 264 | |
| Research and development expenses | 6 | 7 | 7 | 5 | 4 | |
| Selling and marketing expenses | 19 | 18 | 18 | 16 | 15 | |
| General and administrative expenses | 80 | 80 | 68 | 61 | 76 | |
| Other operating income | −15 | −9 | 0 | 0 | — | |
| Impairment of long-lived assets | 12 | 1 | 0 | 33 | 0 | |
| Write-off of unsuccessful exploration and storage activities | 1 | 4 | 4 | 800,000 | 0 | |
| Operating income | 169 | 172 | 167 | 153 | 169 | |
| Interest income | 6 | 8 | 12 | 3 | 2 | |
| Interest expense, net | −142 | −134 | −99 | −88 | — | |
| Derivatives and foreign currency transaction gains (losses) | 5 | −4 | −3 | −6 | −15 | |
| Income attributable to sale of tax benefits | 67 | 73 | 61 | 34 | 30 | |
| Other non-operating income, net | 385,000 | 188,000 | 2 | −709,000 | −134,000 | |
| Income from operations before income tax and equity in earnings (losses) of investees | 106 | 115 | 139 | 96 | 104 | |
| Income tax (provision) benefit | 20 | 16 | −6 | −15 | −25 | |
| Equity in earnings (losses) of investees | 960,000 | −425,000 | 35,000 | −3 | −3 | |
| Net income | 127 | 131 | 133 | 78 | 76 | |
| Net income attributable to noncontrolling interest | −3 | −8 | −9 | −12 | −14 | |
| Net income attributable to the Company's stockholders | 124 | 124 | 124 | 66 | 62 | |
| Change in foreign currency translation adjustments | 10 | −8 | 1 | −3 | −3 | |
| Change in unrealized gains or (losses) in respect of the Company's share in derivatives instruments of unconsolidated investment that qualifies as a cash flow hedge | −1 | 602,000 | −470,000 | 8 | — | |
| Change in unrealized gains or losses in respect of an interest rate swap and cross currency swap derivative instrument that qualifies as a cash flow hedge (net of related tax) | — | — | −4 | −2 | 2 | |
| Other changes in comprehensive income | 45,000 | 50,000 | 53,000 | 59,000 | 228,000 | |
| Comprehensive income | 134 | 125 | 130 | 82 | 79 | |
| Comprehensive income attributable to noncontrolling interest | −5 | −6 | −9 | −11 | −13 | |
| Comprehensive income attributable to the Company's stockholders | 128 | 118 | 121 | 71 | 67 | |
| Basic (in dollars per share) | 2.04 | 2.05 | 2.09 | 1.17 | 1.11 | |
| Diluted (in dollars per share) | 2.02 | 2.04 | 2.08 | 1.17 | 1.1 | |
| Weighted average number of shares used in computation of earnings per share, basic (in shares) | 61 | 60 | 59 | 56 | 56 | |
| Weighted average number of shares used in computation of earnings per share, diluted (in shares) | 61 | 61 | 60 | 57 | 56 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 147 | 94 | 196 | 96 | 239 | |
| Restricted cash and cash equivalents (primarily related to VIEs) | 133 | 111 | 92 | 131 | 104 | |
| Trade less allowance for credit losses of $308 and $224, respectively (primarily related to VIEs) | 165 | 164 | 209 | 129 | 123 | |
| Other | 37 | 51 | 45 | 32 | 18 | |
| Inventories | 45 | 38 | 45 | 23 | 28 | |
| Costs and estimated earnings in excess of billings on uncompleted contracts | 30 | 29 | 18 | 16 | 10 | |
| Prepaid expenses and other | 40 | 59 | 42 | 30 | 36 | |
| Total current assets | 598 | 547 | 646 | 457 | 602 | |
| Investment in unconsolidated companies | 162 | 145 | 125 | 116 | 106 | |
| Deposits and other (primarily related to VIEs) | 138 | 75 | 45 | 40 | 79 | |
| Deferred income taxes | 139 | 154 | 153 | 161 | 143 | |
| Property, plant and equipment, net ($3,460,079 and $3,271,248 related to VIEs, respectively) | 3,673 | 3,502 | 2,999 | — | — | |
| Construction-in-process ($392,644 and $251,442 related to VIEs, respectively) | 1,048 | 756 | 815 | 893 | 721 | |
| Operating leases right of use ($17,236 and $13,989 related to VIEs, respectively) | 42 | 32 | 24 | 23 | 19 | |
| Finance leases right of use (none related to VIEs) | 5 | 3 | 4 | 4 | 6 | |
| Intangible assets, net | 275 | 302 | 308 | 334 | 363 | |
| Goodwill | 168 | 151 | 91 | 90 | 90 | |
| Total assets | 6,247 | 5,666 | 5,208 | 4,612 | 4,426 | |
| Accounts payable and accrued expenses | 235 | 234 | 215 | 149 | 143 | |
| Short term revolving credit lines with banks (full recourse) | 80 | 0 | 20 | — | — | |
| Commercial paper (less deferred financing costs of $17 and $23, respectively) | 100 | 100 | 100 | 0 | — | |
| Billings in excess of costs and estimated earnings on uncompleted contracts | 13 | 23 | 19 | 9 | 9 | |
| Limited and non-recourse (primarily related to VIEs): | 80 | 70 | 57 | 64 | 62 | |
| Full recourse | 214 | 161 | 117 | 101 | 314 | |
| Financing liability | 10 | 4 | 5 | 16 | 11 | |
| Operating lease liabilities | 5 | 4 | 3 | 2 | 3 | |
| Finance lease liabilities | 2 | 1 | 1 | 2 | 3 | |
| Total current liabilities | 738 | 598 | 537 | 344 | 544 | |
| Limited and non-recourse (primarily related to VIEs and less deferred financing costs of $13,488 and $8,849, respectively) | 646 | 578 | 447 | — | — | |
| Full recourse (less deferred financing costs of $4,248 and $4,671, respectively) | 1,009 | 823 | 698 | — | — | |
| Convertible senior notes (less deferred financing costs of $4,103 and $6,820, respectively) | 472 | 470 | 423 | — | — | |
| Financing liability | 207 | 216 | 221 | 226 | 242 | |
| Operating lease liabilities | 30 | 23 | 20 | 20 | 16 | |
| Finance lease liabilities | 3 | 2 | 2 | 2 | 4 | |
| Liability associated with sale of tax benefits | 190 | 152 | 185 | 166 | 135 | |
| Deferred income taxes | 69 | 69 | 67 | 83 | 85 | |
| Liability for unrecognized tax benefits | 10 | 6 | 9 | 7 | 6 | |
| Liabilities for severance pay | 12 | 10 | 12 | — | — | |
| Asset retirement obligation | 136 | 130 | 114 | 98 | 85 | |
| Other long-term liabilities | 34 | 29 | 22 | 3 | 5 | |
| Total liabilities | 3,555 | 3,106 | 2,757 | 2,581 | 2,418 | |
| Commitments and contingencies (Note 20) | — | — | — | — | — | |
| Redeemable noncontrolling interest | 10 | 9 | 11 | 10 | 9 | |
| Common stock, par value $0.001 per share; 200,000,000 shares authorized; 60,845,411 and 60,500,580 issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 61,000 | 61,000 | 60,000 | 56,000 | 56,000 | |
| Additional paid-in capital | 1,655 | 1,635 | 1,615 | 1,259 | 1,272 | |
| Treasury stock, at cost (258,667 shares held as of December 31, 2025 and 2024, respectively) | −18 | −18 | −18 | −18 | — | |
| Retained earnings | 909 | 815 | 720 | 624 | 585 | |
| Accumulated other comprehensive loss | −2 | −7 | −1 | 3 | −2 | |
| Total stockholders' equity attributable to Company's stockholders | 2,544 | 2,425 | 2,315 | 1,868 | 1,855 | |
| Noncontrolling interest | 137 | 126 | 126 | 153 | 143 | |
| Total equity | 2,681 | 2,551 | 2,441 | 2,021 | 1,998 | |
| Total liabilities, redeemable noncontrolling interest and equity | 6,247 | 5,666 | 5,208 | 4,612 | 4,426 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 292 | 263 | 225 | 199 | 183 | |
| Accretion of asset retirement obligation | 8 | 8 | 6 | 5 | 4 | |
| Stock-based compensation | 19 | 20 | 15 | 12 | 9 | |
| Income attributable to sale of tax benefits, net of interest expense | −26 | −22 | −23 | −13 | −12 | |
| Equity in losses (earnings) of investees, net | −960,000 | 425,000 | −35,000 | 3 | 3 | |
| Mark-to-market of derivative instruments | 550,000 | 856,000 | −2 | 2 | 741,000 | |
| Loss (gain) on disposal of property, plant and equipment | −303,000 | 101,000 | 35,000 | −89,000 | 0 | |
| Loss (gain) on severance pay fund asset | −294,000 | −413,000 | 154,000 | 1 | −1 | |
| Loss (gain) on foreign currency exchange rate | −8 | 3 | 0 | 0 | — | |
| Deferred income tax provision | −33 | 5 | −6 | −19 | −3 | |
| Liability for unrecognized tax benefits | 4 | −2 | 2 | 829,000 | 4 | |
| Receivables | 4 | 27 | −98 | −20 | 27 | |
| Costs and estimated earnings in excess of billings on uncompleted contracts | −210,000 | −12 | −2 | −7 | — | |
| Long-term costs and estimated earnings in excess of billings on uncompleted contracts | −49 | −26 | 0 | 0 | — | |
| Inventories | −7 | 7 | −22 | 6 | 4 | |
| Prepaid expenses and other | 821,000 | −9 | −3 | 5 | −19 | |
| Change in operating lease right of use asset | 5 | 4 | 4 | 3 | — | |
| Deposits and other | 6 | −4 | −8 | 3 | −4 | |
| Accounts payable and accrued expenses | −2 | 11 | 69 | −2 | −22 | |
| Billings in excess of costs and estimated earnings on uncompleted contracts | −11 | 5 | 10 | −463,000 | −2 | |
| Liabilities for severance pay | 1 | −1 | −989,000 | −3 | −3 | |
| Change in operating lease liabilities | −6 | −9 | −3 | −4 | — | |
| Other liabilities, net | −3 | 5 | 11 | −2 | −102,000 | |
| Net cash provided by operating activities | 335 | 411 | 309 | 281 | 259 | |
| Capital expenditures | −620 | −488 | −618 | −563 | −419 | |
| Investment in unconsolidated companies | −18 | −19 | −10 | −5 | −6 | |
| Cash paid for acquisition of a business, net of cash acquired | −89 | −275 | 0 | 0 | −171 | |
| Decrease (increase) in severance pay fund asset, net of payments made to retired employees | −213,000 | 1 | 221,000 | 1 | 3 | |
| Net cash used in investing activities | −726 | −780 | −628 | −523 | −638 | |
| Proceeds from long-term loans, net of transaction costs | 549 | 515 | 150 | 135 | — | |
| Proceeds from exercise of options by employees | 0 | 0 | 314,000 | 39,000 | 0 | |
| Proceeds from issuance of common stock, net of stock issuance costs | 0 | 0 | 342 | 0 | 311,000 | |
| Proceeds from issuance of convertible notes, net of transaction costs | 0 | 44 | 0 | — | — | |
| Proceeds related to tax monetization transactions | 152 | 0 | 42 | — | — | |
| Proceeds from issuance of commercial paper, net of transaction costs | 0 | 0 | 100 | 0 | 0 | |
| Proceeds from revolving credit lines with banks | 1,974 | 186 | 55 | 0 | 0 | |
| Repayment of revolving credit lines with banks | −1,894 | −206 | −35 | 0 | — | |
| Cash received from noncontrolling interest | 10 | 12 | 7 | 5 | 5 | |
| Transaction with noncontrolling interest | 0 | −10 | −30 | 0 | 0 | |
| Repayments of long-term debt and financing liability | −265 | −209 | −207 | — | — | |
| Cash paid to noncontrolling interest | −8 | −6 | −10 | −6 | −7 | |
| Payments under finance lease obligations | −2 | −1 | −2 | −3 | −3 | |
| Deferred debt and tax monetization transactions issuance costs | −21 | −7 | −4 | −2 | −1 | |
| Cash dividends paid | −29 | −29 | −28 | −27 | −27 | |
| Net cash provided by (used in) financing activities | 466 | 288 | 380 | 126 | 186 | |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents | 682,000 | −579,000 | 72,000 | −609,000 | −348,000 | |
| Net change in cash and cash equivalents and restricted cash and cash equivalents | 75 | −82 | 61 | −117 | −193 | |
| Interest, net of interest capitalized | 112 | 103 | 72 | 69 | 67 | |
| Income taxes, net of refunds | 10 | 26 | 26 | 29 | 34 | |
| Increase (decrease) in accounts payable related to purchases of property, plant and equipment | −9 | −3 | −12 | 5 | 8 | |
| Right of use assets obtained in exchange for new lease liabilities | 16 | 13 | 6 | 9 | — | |
| Increase in asset retirement cost and asset retirement obligation | −6 | 740,000 | 11 | 8 | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is ORMAT TECHNOLOGIES, INC.'s CIK number?
ORMAT TECHNOLOGIES, INC.'s SEC CIK number is 0001296445 (1296445). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find ORMAT TECHNOLOGIES, INC.'s SEC filings?
All of ORMAT TECHNOLOGIES, INC.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did ORMAT TECHNOLOGIES, INC. last report earnings?
ORMAT TECHNOLOGIES, INC. (ORA) most recently filed an earnings 8-K with the SEC on May 6, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001437749-26-015235). This is ORMAT TECHNOLOGIES, INC.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is ORMAT TECHNOLOGIES, INC.'s most recent earnings 8-K?
ORMAT TECHNOLOGIES, INC.'s latest earnings 8-K (Item 2.02) was filed May 6, 2026 under accession 0001437749-26-015235. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View ORMAT TECHNOLOGIES, INC.'s latest earnings 8-K →
Look up any company's CIK number →